The effect of puerarin (Pur) on expressions of Fas/FasL mRNAs in pulmonary ischemia and reperfusion injury (PIRI) in rabbit was investigated. The sole side lung ischemia and reperfusion model was used. Rabbits were randomly divided into three groups, a sham operated group (sham, n = 10), PIR group (IR, n =30) and PIR + Pur group (Pur, n =30). Changes of several parameters including apoptotic index (AI), wet to dry ratio of lung tissue weight (W/D) and index of quantitative assessment of histologic lung injury (IQA) were measured after 60, 180 and 300 minutes of reperfusion. Meanwhile, the location and expression of Fas/FasL mRNA were investigated. Lung tissue was prepared for light microscopic and electron microscopic observation after 60, 180 and 300 minutes of reperfusion. Compared with group IR, Fas/FasL mRNAs were slightly expressed in intima and extima of small pulmonary artery, alveoli, and bronchiole epithelia in group Pur. The values of AI, W/D and IQA were significantly lower than those in group IR after 60, 180, and 300 minutes of reperfusion in lung tissue (P <0.01 or P <0.05). Meanwhile, the abnormal changes in lung tissue morphology were markedly less in group Pur. Puerarin notably protects lung from PIRI by inhibiting Fas/FasL mRNA expression and decreasing lung cell apoptosis in rabbits.
In recent years, surgical operations, such as pulmonary artery sleeve resection, lung transplantation, combined heart and lung transplantation, and pulmonary thrombolytic therapy have been established and developed [1] [2] [3] . However, pulmonary ischemiareperfusion injury (PIRI) is still one important factor influencing the prognosis of transplantation and thrombolytic therapy. Preventing the occurrence of such reperfusion damage might be an important therapeutic strategy in conserving the organ's long-term function [4] . Accordingly, research is urgently needed into means to antagonize PIRI.
Puerarin, a monomer extracted from the traditional Chinese herb radix puerariae {Pueraria lobata (Wild.) Ohwi; Gegen}, has neuroprotection effects and plays an anti-inflammatory role in focal cerebral ischemia model rats [5, 6] . Several preclinical studies have demonstrated that puerarin protects the brain against inflammation through decreasing the expression of TNF-α following cerebral ischemia-reperfusion (IR) injury [7, 8] . Selective activation of A 1 , A 2A , or A 3 adenosine receptors provided significant protection against lung IR injury, and the decrease in TNF-α likely contributed to the overall improvement in pulmonary function [2] .
Fas is a transmembrane protein that belongs to the tumor necrosis factor (TNF) superfamily. Fas protein is expressed in hepatocytes, cholangiocytes, sinusoidal endothelial cells, and Kupffer cells . The death receptor engagement by its corresponding ligand FasL causes receptor activation and the beginning of the apoptotic cascade [9] . Mild hypothermia decreases infarct volume after cerebral IR, reduces Fas expression, but increases FasL in cerebral IR rats [10] . Fas/FasL is also known to be involved in the pathogenesis of kidney IR injury [11] .
In an earlier study [12] , to find out how puerarin influences them, we observed the site-specific expression of Fas/FasL mRNA in lung tissue, apoptotic index (AI), wet to dry ratio of lung tissue weight (W/D), index of quantitative assessment of histologic lung injury (IQA) and morphological changes of lung tissue in PIRI animal models. Here we have made a preliminarily study exploring the mechanism of antagonizing PIRI in order to provide a theoretical basis for strengthening lung protection at the perioperative stage.
Changes of expression level of Fas-mRNA and FasL-mRNA in rabbits during PIR among 3 groups
Group Sham: There was no noticeable brownish-yellow positive signal in lung tissue, indicating that expression of Fas-mRNA and FasL-mRNA was not obvious. Compared with group IR and group Pur, expressions of Fas-mRNA and FasL-mRNA were significantly stronger than in group Sham (each P <0.01). Expression of Fas-mRNA and FasL-mRNA in subgroups of group Pur was significantly weaker than those of group IR at the same time point (each P <0.01). Positive cells were mainly distributed in the pulmovascular endothelial, lung epithelial, and thin bronchial epithelial cells, and was also expressed on stromal cells to a small extent (Tables 1-2, Figures 1-2). P<0.01 vs. sham; ▲▲ P<0.01 vs. IR; **P<0.01 vs. reperfusion 1 h in the same group; R: reperfusion. 
Changes in AI values of lung tissue in rabbits during PIR among 3 groups
A small number of apoptotic cells were seen in group Sham after 1, 3 and 5 h of reperfusion. The AI value of group IR was significantly greater than that of group Sham (each P <0.01), especially at the end of 3 h reperfusion. The AI value of group Pur was significantly less than that of group IR (each P <0.01), but still significantly greater than that of group Sham (P <0.01), especially at the end of 3 h of reperfusion (Table 3, Figure 3 ).
Changes in W/D values of lung tissue in rabbits during PIR among 3 groups
Confirmed by ANOVA analysis, after 1, 3 and 5 h of reperfusion, the W/D value of group IR was significantly greater than that of group Sham (each P <0.01). The W/D value of group Pur was significantly less than that of group IR (each P <0.01)). Compared with group Sham, there was no significant difference at the end of 1h of reperfusion (P> 0.05) (Table. 4 ).
Changes in IQA values of lung tissue in rabbits during PIR among 3 groups:
Confirmed by ANOVA analysis, after 1, 3 and 5 h of reperfusion, the IQA value of group IR was significantly greater than that of group Sham (each P <0.01). The IQA value of group Pur was significantly less than that of group IR (each P <0.01)), but still significantly greater than that of group Sham at the end of 3 and 5 h of reperfusion (each P <0.01) ( Table 5) .
The relationship between all parameters AI, W/D, IQA and Fas/FasL-mRNA of lung tissue: Linear correlation analysis showed that the AI value appeared to have a positive correlation with the optical density values of Fas and FasL in situ hybridization (r=0.842, 0.805 respectively, each P<0.01). The AI value appeared to have a significant positive correlation with W/D and IQA (r=0.876, 0.888 respectively, each P<0.01). The W/D value showed significant positive correlation with the optical density values of Fas and FasL in situ hybridization (r=0.712, 0.748 respectively, each P<0.01). The IQA value appeared to have a significant positive correlation with the optical density values of Fas and FasL in situ hybridization (r=0.775, 0.824 respectively, each P<0.01).
Morphological changes in lung tissue
Under light microscope: In group Sham, the pulmonary interstitium and alveoli were complete and without infiltration of inflammatory cells. The alveoli were obviously damaged in group IR, which also showed pulmonary interstitial edema and widening, inflammatory cell infiltration, and more effusion of blood components. In group Pur, the alveoli were more complete than in group IR. Group Pur showed mild pulmonary interstitial edema and a small amount of inflammatory cell infiltration (Figure 4 ). Electron microscopy: In group Sham, the structure of the capillary endothelial cells was normal, but in group IR, there appeared more endocytic vesicles in the endochylema of the pulmonary microarterial endothelial cells. The mitochondria were swollen, with vacuoles. Subintimal basement membrane edema and degeneration were also shown. The capillary cavity was plugged with PMN. The mitochondria were swollen in the type II alveolar epithelial cells, and the lamellar bodies were decreased. In group Pur, the structure of the pulmonary microarterial endothelial cells and capillary endothelial cells was basically normal and connected closely. Compared with group Pur, the structure of mitochondria was basically normal with less edema, and capillary PMN was less. The morphological structure of type II alveolar epithelial cells showed no significant abnormality. There was no obvious defluxion of microvilli. Mitochondrial swelling was not distinct, the number of lamellar bodies did not apparently reduce, and there was no obvious PMN infiltration into the alveolar interstitium ( Figure 5 ).
Fas is a type I glycoprotein transmembrane receptor belonging to the TNF receptor/growth factor receptor superfamily. On the cellular membrane it can be divided into intracellular regions, transmembrane domain and extracellular domain. Its intracellular region contains a piece of about 60-70 amino acids that is the death domain (DD). Fas exists mainly in the form of membrane receptors, but through different transcription levels the body can also produce soluble Fas (sFas), which can connect with FasL to induce apoptosis of alveolar epithelial cells and endothelial cells. FasL is a type Ⅱ membrane protein in the TNF family. In the region of genetic transcription regulation there exist binding sites of such transcription regulation factors as IRF-1, SP-1 and NF-κB. These binding sites play an important role in genetic expression and can combine with Fas to induce an apoptosis Fas system composed of Fas. Fas can transduce apoptosis signals into cells, which may be the main way of causing apoptosis in lung ischemia-reperfusion injury. Galani et al. [13] found that in ARDS both proximal epithelial cells of the airway and distal alveolar epithelial cells can express Fas, but the two have different sensitivities to FasL, and pro-inflammatory cytokines such as TNF-α, IL-1β, and INF-γ can make the sensitivity of alveolar epithelium to FasL increase causing apoptosis. It has been reported by Okazaki [14] that in acute lung injury, Fas/FasL can mediate apoptosis of epithelial cells, and the combination of Fas and FasL can also activate NF-κB and promote the release of pro-inflammatory mediators, then cause an inflammation reaction. This study finds that the changes of Fas/FasL-mRNA expression and AI value are consistent and significantly positively correlated, and it is suggested that the Fas/FasL system mediates apoptosis in pulmonary ischemiareperfusion injury [8] . The change of Fas/FasL-mRNA expression level presents significant positive correlation with the better sensitivity indicators W/D and IQA values reflecting the extent of lung tissue damage. This indicates that the Fas/FasL system is involved in the activation and development PIRI.
Our results showed that in group IR, the W/D and IQA values of lung tissue significantly increased, and the morphological structure showed abnormal changes. After using puerarin, there was only a slight increase in W/D and IQA values, which were significantly lower than those of group IR, and the abnormal morphological changes in lung tissue were obviously less. This showed that puerarin had a certain cell-protection effect on pulmonary ischemiareperfusion injury. According to the results, in group Pur the expression of Fas/FasL-mRNA and the AI value were significantly lower than in group IR. Moreover, the AI value and the expression of Fas/FasL-mRNA showed a significant linear correlation. This pointed out that puerarin may lessen apoptosis through downregulating the expression of Fas/FasL mRNA in lung tissue, and then antagonizing PIRI. Past research has shown that puerarin can effectively prevent and treat PIRI by reducing the level of oxygen free radicals and lipid peroxidation [15] . At the same time, puerarin can curb PIRI through effectively restraining platelet adhesion and aggregation in circulatory blood and regulating the balance between thromboxane A 2 and prostacyclin to impede the "no-reflow phenomenon", thus preventing and treating PIRI [16] . In addition, puerarin can increase the level of nitric oxide in the body and reduce the level of endothelin to inhibit indirectly PMN adhesion and aggregation [16, 17] , then prevent the damage caused to the lung tissue by oxygen free radicals, and effectively reduce PIRI. Of course, puerarin can block specific voltage-operated and receptordependent calcium channels to stop the influx of extracellular calcium, and then reduce the intracellular calcium overload [18] to a certain extent, and effectively prevent and treat PIRI.
Experimental
Preparation of animal models: Seventy rabbits (either gender), weighing 2.0～2.5 kg, were anesthetized with ethyl carbamate (i.v 1.0 g/kg). The trachea was opened, intubated, and then connected to the breathing machine, which was ventilated with pure O 2 (bilateral lung 10 mL/kg ventilation 15-20 mL/kg) at breaths 30/min and breath ratio 1:1.25. The unilateral external jugular vein was separated, intubated, and injected with 0.9% N.S 0.5-1.5 mL/kg i.v. The chest between the 4 th and 5 th rib on the left was opened, after dissociating the porta of the left lung, catheterizing the blocking belt, and then heparin (i.v 1.0 mg/kg) was added as an anticoagulant. The rabbit PIRI model was established according to the Sekido method [19] by blocking blood vessels and trachea of the porta of the left lung completely with desmurgia for 1 h, and then recovering the blood supply and venting.
Experimental grouping: Rabbits were divided into 3 groups randomly: ①Sham operation control group (group sham, 10 rabbits), The porta of the left lung was dissociated, and then observed for 4 h. ②Ischemia-reperfusion group (group IR), which included 3 subgroups (10 rabbits in each subgroup). Each subgroup was reperfused for 1, 3 or 5 h, respectively. The porta of the left lung was blocked for 1 h, then opened to reperfuse for 5 h. ③Lung ischemia-reperfusion + puerarin group (group Pur, 10 rabbits), puerarin (KangEnBei pharmaceuticals Limited Co., Zhejiang, 100 mg/2 mL, batch number 228901) was injected into the auricular vein 30 mg/kg. The left process was the same as group IR.
In-situ hybridization analysis of Fas and FasL in lung tissue
Processing of lung tissue sample: Samples were dehydrated by fixing in 75%, 85%, 95% and 100% ethanol, each time for 30 min, and then embedded in paraffin. The embedded samples were cut into 5 μm thick slices, which then were mounted on slides coated by polylysine.
Oligonucleotide probe sequence of Fas and FasL:
Oligonucleotide probe sequence of Fas: 5'-TTTGT TCGGA AGAAT GGTGT TAATG AAGCC AAAAT -3'; 5'-AAAAG CTAAT CTTTG TGCTC TTGCG GAGAA AATTC -3′; Oligonucleotide probe sequence of FasL: 5′-CCCAG ATCTA CTGGG TG GAC AGCAG TGCCA-3′; 5′-TATTC CAAAG TATAC TTCCG GGGTC AATCT -3′; 5′-CTCTC TGGTC AATTT TGAGG AATCT CAGAC -3′.
In-situ hybridization steps: Slices were deparaffinized with xylene, rehydrated in a graded series of ethanol, and washed in PBS. Fas/FasL was detected using the In SituHybridization Detection Kit (Boster, Wuhan, China) according to the manufacturer's instructions. Briefly, the slices were hybridized with Fas and FasL oligonucleotide probe for 17 h at 42°C and incubated with biotinylated mouse anti-digoxigenin antibody, then incubated with biotinylated peroxidase. After staining with DAB, the slices were counterstained with hematoxylin, dehydrated and mounted.
The number of cells staining brown-yellow was assessed by light microscopy (Olympus Hamburg, Germany), and the micrographs
